China Anlotinib Hydrochloride Market Analysis, Application & Forecast To 2021-2025

Submitted by James Grey | December 4, 2021, 07:44:40 | Business

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Article source: https://www.bharatbook.com/report/1058810/research-report-on-chinas-anlotinib-hydrochloride-market

Tag: #china anlotinib hydrochloride market #china anlotinib hydrochloride market repor

You May Interested More:

Healthcare Management Solutions

TAGNOS™ is one of the best hospital management system that delivers specialized hospital management software solutions, The Tagnos Software plays an important role in simplifying the workflow of hospitals, digitizing….

Why The Role Of Nurses Is Important In Healthcare

Look up and find caring nurses across the USA. Generate more sales and expand your business with our nurses email list.The role of nurses in the healthcare industry is important…..

How To Overcome Serious Indecisiveness With Lma Course Review

Those people who want to go far in their journey can contact our expert coaches and enroll in our lma course review program where they will get the best assistance….

Qatar Coagulation Testing Market Opportunity And Forecast (2022-2026)

Qatar Coagulation Testing Market Report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next….

Your email address will not be published.

*